People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes ...

Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, ...

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

Edwards Lifesciences today shared new data demonstrating successful outcomes with its mitral and tricuspid therapies.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

Trey Yesavage rocks back to deliver a pitch and his arm whips down from behind his head as his body tilts to the left, the ...

There are various challenges in ensuring small manufacturers can maintain smooth production processes, and one important ...

NEWTOWN, PA — Micro Interventional Devices (MID) announced that the U.S. Food and Drug Administration (FDA) has granted ...